Three independent batch files
BPC-157, SS-31, and TB-500 each ship with their own paperwork.
$213.97
Questions before ordering? Our team can confirm documentation, stock and shipping.
Specifications for each compound are listed individually below.
| Compound | BPC-157 | SS-31 | TB-500 |
|---|---|---|---|
| Quantity | 5mg | 10mg | 5mg |
| Product format | Research-grade pentadecapeptide | Research-grade tetrapeptide | Research-grade synthetic peptide fragment |
| Intended use | Laboratory research only | Laboratory research only | Laboratory research only |
| Documentation | COA available through our COA library | COA available through our COA library | COA available through our COA library |
| Related category | Tissue Repair & Regeneration Research | Mitochondrial & Metabolic Peptide Research | Tissue Repair & Regeneration Research |
This bundle is distributed strictly for scientific and laboratory research, and none of the three compounds carry approval for human or animal use, diagnosis, or treatment.
Look over the compliance section and each compound's storage guidance before submitting an order.
Rodent Achilles tendon transection studies have compared BPC-157 and TB-500 directly, finding both improved histopathological markers and collagen organization during early repair, with TB-500 showing a measurable biomechanical edge by week four, largely attributed to its actin-binding role in driving fibroblast and keratinocyte migration toward the injury site. BPC-157, by contrast, is studied for upregulating growth factor expression and modulating nitric oxide signaling, effects tied more to localized angiogenesis and fibroblast proliferation than to migration itself.
SS-31 addresses a layer of recovery biology that neither peptide touches directly. Skeletal muscle surrounding an injury site experiences its own mitochondrial oxidative stress, and SS-31 is studied for binding cardiolipin in the inner mitochondrial membrane, a mechanism shown in aged and ischemic muscle models to restore ATP production and improve functional recovery. Because the three compounds sit at different points along the recovery timeline, tissue-level repair versus muscle-level energetics, researchers use this bundle to study the two processes as separate but co-occurring variables.
Each compound occupies a distinct role in recovery-focused research.
Each of the three vials in this bundle carries its own batch record, so a lot can be checked on its own terms rather than against a single certificate covering the full set.
The documentation approach here matches every listing across the Cellugenix catalog.
BPC-157, SS-31, and TB-500 each ship with their own paperwork.
Identity and purity for every batch are verified by a third party.
None of the three compounds are marketed beyond laboratory use.
All three vials travel together under one tracking number.
Each vial is individually secured within the shipment.
Two connective-tissue peptides and one mitochondrial-targeted compound don't share one storage profile, so treat each vial according to its own requirements.
This bundle spans two categories across the Cellugenix catalog.
Reference pages for testing standards and ordering policy.
BPC-157 at 5mg, SS-31 at 10mg, and TB-500 at 5mg, each shipped as its own documented vial.
BPC-157 and TB-500 act on tissue-level repair signaling, while SS-31 targets mitochondrial function within the surrounding muscle, addressing energy metabolism rather than tendon or connective tissue structure directly.
Yes. Rat Achilles tendon studies have tested both peptides side by side, with TB-500 showing a biomechanical advantage at four weeks in that specific model.
Yes, BPC-157, SS-31, and TB-500 each have an independent batch record accessible through the COA library.
No, each has its own stability profile, so check the individual handling page for BPC-157, SS-31, and TB-500 separately.
Weighing quantities, checking lead times, or have another question before you place this order? Our team is ready to help you work through it.